A 59-Year-Old Woman with Extensive Deep Vein Thrombosis and Pulmonary Thromboembolism 7 Days Following a First Dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine
A case of fulminant type 1 diabetes mellitus after COVID-19 vaccination during treatment of advanced gastric cancer, pitfall in managing immune-related adverse events
Current state of knowledge on the excretion of mRNA and spike producedbyanti-COVID-19 mRNA vaccines, possibility of contamination of the entourageofthose vaccinated by these products.pdf